BACCEGA, TANIA
BACCEGA, TANIA
Facoltà di Medicina e Chirurgia
Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacement
2022-01-01 Chimienti, Raniero; Baccega, Tania; Torchio, Silvia; Manenti, Fabio; Pellegrini, Silvia; Cospito, Alessandro; Amabile, Angelo; Lombardo, Marta Tiffany; Monti, Paolo; Sordi, Valeria; Lombardo, Angelo; Malnati, Mauro; Piemonti, Lorenzo
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC for cell therapy of type 1 diabetes
2019-01-01 Chimienti, R; Baccega, T; Manenti, F; Torchio, S; Pellegrini, S; Pritchard-Meaker, T; Sordi, V; Lombardo, A; Malnati, M; Piemonti, L
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC-derived β cells for cell therapy of type 1 diabetes
2020-01-01 Chimienti, R; Baccega, T; Manenti, F; Torchio, S; Pellegrini, S; Cospito, A; Monti, P; Sordi, V; Lombardo, A; Malnati, M; Piemonti, L
Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis
2020-01-01 Caputo, S.; Grioni, M.; Brambillasca, C. S.; Monno, A.; Brevi, A.; Freschi, M.; Piras, I. S.; Elia, A. R.; Pieri, V.; Baccega, T.; Lombardo, A.; Galli, R.; Briganti, A.; Doglioni, C.; Jachetti, E.; Bellone, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacement | 1-gen-2022 | Chimienti, Raniero; Baccega, Tania; Torchio, Silvia; Manenti, Fabio; Pellegrini, Silvia; Cospito, Alessandro; Amabile, Angelo; Lombardo, Marta Tiffany; Monti, Paolo; Sordi, Valeria; Lombardo, Angelo; Malnati, Mauro; Piemonti, Lorenzo | |
| Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC for cell therapy of type 1 diabetes | 1-gen-2019 | Chimienti, R; Baccega, T; Manenti, F; Torchio, S; Pellegrini, S; Pritchard-Meaker, T; Sordi, V; Lombardo, A; Malnati, M; Piemonti, L | |
| Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC-derived β cells for cell therapy of type 1 diabetes | 1-gen-2020 | Chimienti, R; Baccega, T; Manenti, F; Torchio, S; Pellegrini, S; Cospito, A; Monti, P; Sordi, V; Lombardo, A; Malnati, M; Piemonti, L | |
| Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis | 1-gen-2020 | Caputo, S.; Grioni, M.; Brambillasca, C. S.; Monno, A.; Brevi, A.; Freschi, M.; Piras, I. S.; Elia, A. R.; Pieri, V.; Baccega, T.; Lombardo, A.; Galli, R.; Briganti, A.; Doglioni, C.; Jachetti, E.; Bellone, M. |